Make a referral


Our impact in 2023

0 k
Net Promoter Score
App reviews

In 2023, we continued to empower our members to reach their addiction recovery goals. Here are some highlights:

Measured what matters most

We added three new regularly scheduled, measurement-based assessments to improve tracking of recovery metrics for individuals and our aggregate member population.

Substance Use Recovery Evaluator (SURE)

GAD-7 for anxiety

PHQ-9 for depression

Published outcomes and presented research

Workit Labs, the research arm of Workit Health, enhanced our reputation for credibility and clinical rigor with presentations at conferences and peer-reviewed articles in academic journals.

Rising Patient Volume and Acuity Challenge Mental and Behavioral Health Care Access

December 20, 2023

by M. Justin Coffey, M.D. Published in NEJM Catalyst Innovations in Care Delivery

Retention in Telehealth Treatment for Opioid Use Disorder among Pregnant People

June 20, 2023

Presented at the 2023 College on Problems of Drug Dependence Meeting

Innovations in Small Business Telehealth Technologies for Substance Use Disorders: Automated Assessments, Electronic Health Record Integrations, and Medication Shipping

June 19, 2023

Poster presented at the 2023 College on Problems of Drug Dependence Meeting.

Chatbots: Increasing Patient and Provider Engagement in Substance Use Disorder Care

May 21, 2023

Presented at the 2023 American Psychiatric Association Meeting

Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations: A Retrospective Cohort Study

May 15, 2023

Published in Telemedicine and e-Health

Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations

April 14, 2023

Poster presented at the American Society of Addiction Medicine 54th Annual Conference

Shared our insights

Members of the Workit Health team took part in thought leadership discussions, presentations, and panels, both in-person and online.

Learned from clinical innovators

Workit Health hosted 11 visiting lecturers for Grand Rounds and has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit to PAs who participate. All staff are welcome to attend these educational sessions, on subjects including:

  • Equity-based Telehealth Access to Medication for Opioid Use Disorder and Medication-assisted Treatment
  • Diagnosing and Managing PTSD in Individuals with SUD
  • Comorbid Psychiatric and Alcohol Use Disorders
  • Buprenorphine Initiation Strategies
  • Identification and Management of Buprenorphine/Naloxone Side Effects


Received national recognition

Increased access to care

Workit Health is honored to be a recipient of the RCORP–Medication Assisted Treatment (MAT) Access award to expand telehealth substance use disorder treatment access points in several Ohio counties.

Thank you for supporting our mission to change the way addiction is treated in America

This site uses cookies to improve your experience. By using this site, you consent to our use of cookies.